Clinical experience with Sandostatin LAR ( R) in patients with acromegaly

By Heijckmann C.A.   Menheere P.P.C.A.   Sels J.-P.J.E.   Beuls E.A.M.   Wolffenbuttel B.H.R.  

The Netherlands Journal of Medicine, Vol. 59, Iss. 6, 2001-12 ,pp. : 286-291

Elsevier

Access to resources Recommend Favorite

Sandostatin^® LAR^® Leaders Meeting – European Neuroendocrine Tumour Network ENET

By  

Digestion, Vol. 62, Iss. 1, 2000-07 ,pp. : 98-107

Karger

Access to resources Recommend Favorite

Influence of Somatostatin Receptor Scintigraphy and CT/MRI on the Clinical Management of Patients with Gastrointestinal Neuroendocrine Tumors: An Analysis in 188 Patients

By  

Digestion, Vol. 68, Iss. 2-3, 2004-01 ,pp. : 80-85

Karger

Access to resources Recommend Favorite

Regression of a Large Malignant Gastrinoma on Treatment with Sandostatin LAR®: A Case Report

By  

Digestion, Vol. 77, Iss. 2, 2008-03 ,pp. : 92-95

Karger

Access to resources Recommend Favorite

Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumors

By Ito Tetsuhide   Tanaka Masao   Sasano Hironobu   Osamura Yoshiyuki R.   Sasaki Iwao   Kimura Wataru   Takano Koji   Obara Takao   Ishibashi Miyuki   Nakao Kazuwa   Doi Ryuichiro   Shimatsu Akira   Nishida Toshirou   Komoto Izumi   Hirata Yukio   Imamura Masayuki   Kawabe Ken   Nakamura Kazuhiko  

Journal of Gastroenterology, Vol. 42, Iss. 6, 2007-06 ,pp. : 497-500

Springer Publishing Company

Access to resources Recommend Favorite